Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients
Abstract Most patients infected with SARS-CoV-2 are asymptomatic or mildly symptomatic. However, the early and late antibody kinetics, and the association between antibody levels, clinical symptoms, and disease phase in these patients have not yet been fully defined. Confirmed SARS-CoV-2 patients an...
Guardado en:
Autores principales: | Shai Efrati, Merav Catalogna, Ramzia Abu Hamed, Amir Hadanny, Adina Bar-Chaim, Patricia Benveniste-Levkovitz, Refael Strugo, Osnat Levtzion-korach |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d96d027b0354b4aab45a096bfa175fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations
por: Shai Efrati, et al.
Publicado: (2021) -
Comorbidity burden may explain adiponectin’s paradox as a marker of increased mortality risk in hemodialysis patients
por: Ilia Beberashvili, et al.
Publicado: (2021) -
Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form
por: Annа Malkova, et al.
Publicado: (2021) -
Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19
por: Seongman Bae, et al.
Publicado: (2021) -
Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms
por: S. V. Balakhonov, et al.
Publicado: (2020)